Phase I trial of NLX E201, a gene therapy for the treatment of epilepsy
Phase of Trial: Phase I
Latest Information Update: 07 Dec 2007
At a glance
- Drugs NLX E201 (Primary)
- Indications Epilepsy
- Focus Adverse reactions
- 07 Dec 2007 Neurologix has received a grant from the Epilepsy Research Foundation and will use it to fund this trial which is expected to begin in early 2008.
- 15 Nov 2007 New trial record.